Literature DB >> 29214068

Diagnosis and management of malignant pleural effusions: state of the art in 2017.

Neeraj R Desai1, Hans J Lee2.   

Abstract

Malignant pleural effusion (MPE) is a known complication of both thoracic and extra thoracic malignancies. The presence of MPE regardless of the primary site translates into advanced stage disease. Diagnosis and management of MPE with the goals of palliation and improving quality of life poses a challenge for chest physicians. Recently, multiple studies have made attempts to answer questions regarding optimal management in various clinical scenarios. We will review the current evidence and available options for the management of MPE.

Entities:  

Keywords:  Malignant pleural effusion (MPE); medical thoracoscopy; pleurodesis; thoracentesis; tunneled pleural catheter (TPC)

Year:  2017        PMID： 29214068      PMCID： PMC5696546          DOI： 10.21037/jtd.2017.07.79

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


  88 in total

Review 1.  Thoracoscopy: medical versus surgical-in the management of pleural diseases.

Authors:  Samira Shojaee; Hans J Lee
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

2.  Effect of thoracentesis on respiratory mechanics and gas exchange in the patient receiving mechanical ventilation.

Authors:  Peter Doelken; Ricardo Abreu; Steven A Sahn; Paul H Mayo
Journal:  Chest       Date:  2006-11       Impact factor: 9.410

Review 3.  Pleurodesis for malignant pleural effusions.

Authors:  P Shaw; R Agarwal
Journal:  Cochrane Database Syst Rev       Date:  2004

Review 4.  Malignant pleural mesothelioma: evaluation with CT, MR imaging, and PET.

Authors:  Zhen J Wang; Gautham P Reddy; Michael B Gotway; Charles B Higgins; David M Jablons; Mohan Ramaswamy; Randall A Hawkins; W Richard Webb
Journal:  Radiographics       Date:  2004 Jan-Feb       Impact factor: 5.333

5.  The value of multiple fluid specimens in the cytological diagnosis of malignancy.

Authors:  L W Garcia; B S Ducatman; H H Wang
Journal:  Mod Pathol       Date:  1994-08       Impact factor: 7.842

6.  A comparison of rotation and nonrotation in tetracycline pleurodesis.

Authors:  S R Dryzer; M L Allen; C Strange; S A Sahn
Journal:  Chest       Date:  1993-12       Impact factor: 9.410

7.  Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma. A randomized trial of local radiotherapy.

Authors:  C Boutin; F Rey; J R Viallat
Journal:  Chest       Date:  1995-09       Impact factor: 9.410

8.  Prospective study to determine the volume of pleural fluid required to diagnose malignancy.

Authors:  Jennifer Swiderek; Samer Morcos; Vijayalakshmi Donthireddy; Rajesh Surapaneni; Vicki Jackson-Thompson; Lonni Schultz; Sudha Kini; Paul Kvale
Journal:  Chest       Date:  2009-09-09       Impact factor: 9.410

9.  Complications of indwelling pleural catheter use and their management.

Authors:  Macy M S Lui; Rajesh Thomas; Y C Gary Lee
Journal:  BMJ Open Respir Res       Date:  2016-02-05

10.  Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score.

Authors:  Amelia O Clive; Brennan C Kahan; Clare E Hooper; Rahul Bhatnagar; Anna J Morley; Natalie Zahan-Evans; Oliver J Bintcliffe; Rogier C Boshuizen; Edward T H Fysh; Claire L Tobin; Andrew R L Medford; John E Harvey; Michel M van den Heuvel; Y C Gary Lee; Nick A Maskell
Journal:  Thorax       Date:  2014-08-06       Impact factor: 9.139
View more
  17 in total

1.  Hemorrhagic Malignant Pleural Effusion: Diagnosis, Survival Rate, and Response to Talc Pleurodesis.

Authors:  Gadi Lending; Yousef Abed El Ghani; Edward Kaykov; Boris Svirsky; Hector Isaac Cohen; Edward Altman
Journal:  Indian J Surg Oncol       Date:  2020-11-14

2.  Drug-eluting beads bronchial arterial chemoembolization plus intercostals arterial infusion chemotherapy is effective and well-tolerated in treating non-small cell lung cancer patients with refractory malignant pleural effusion.

Authors:  Xiaofei Liu; Hu Lin; Qin Wang; Mi Mu; Pan Pan; Fangfang Tian; Rui Zhang; Weiguo Zhao; Pengtao Bao
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

3.  Developing a Prediction Score for the Diagnosis of Malignant Pleural Effusion: MPE Score.

Authors:  Chaichana Chantharakhit; Nantapa Sujaritvanichpong
Journal:  Asian Pac J Cancer Prev       Date:  2022-01-01

4.  Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer.

Authors:  Tian Fu; Yong Lin; Qingdi Zeng; Wei Yao; Liping Han
Journal:  BMC Pulm Med       Date:  2020-06-18       Impact factor: 3.317

5.  Elevated Hsp90-beta contributes to differential diagnosis of pleural effusion caused by lung cancer and correlates with malignant biological behavior of lung cancer.

Authors:  Rong Biaoxue; Li Min; Fu Tian; Gao Wenlong; Liu Hua
Journal:  BMC Pulm Med       Date:  2018-12-06       Impact factor: 3.317

6.  Liquid biopsy-based single-cell metabolic phenotyping of lung cancer patients for informative diagnostics.

Authors:  Ziming Li; Zhuo Wang; Yin Tang; Xiang Lu; Jie Chen; Yu Dong; Baojun Wu; Chunying Wang; Liu Yang; Zhili Guo; Min Xue; Shun Lu; Wei Wei; Qihui Shi
Journal:  Nat Commun       Date:  2019-08-26       Impact factor: 14.919

Review 7.  Malignant Pleural Effusion and Its Current Management: A Review.

Authors:  Kristijan Skok; Gaja Hladnik; Anja Grm; Anton Crnjac
Journal:  Medicina (Kaunas)       Date:  2019-08-15       Impact factor: 2.948

8.  Negative SARS-COV-2 pleural effusion in breast carcinoma coincide with COVID-19 infection: Case report.

Authors:  Eko Setiawan; Dian Ayu Listiarini; Shafira Zahra Ovaditya
Journal:  Ann Med Surg (Lond)       Date:  2021-04-18

9.  Indwelling pleural catheters for malignancy-associated pleural effusion: report on a single centre's ten years of experience.

Authors:  Nikolaj Frost; Martin Brünger; Christoph Ruwwe-Glösenkamp; Matthias Raspe; Antje Tessmer; Bettina Temmesfeld-Wollbrück; Dirk Schürmann; Norbert Suttorp; Martin Witzenrath
Journal:  BMC Pulm Med       Date:  2019-12-02       Impact factor: 3.317

10.  Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion.

Authors:  Yuan Yang; Li Ma; Xin Qiao; Xin Zhang; Shu-Feng Dong; Min-Ting Wu; Kan Zhai; Huan-Zhong Shi
Journal:  Transl Lung Cancer Res       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.